RESUMEN
AIM: This study evaluated using urine dipstick tests with the clean-catch method to screen for urinary tract infection (UTI) in febrile infants under 90 days of age. METHODS: We carried out a comparative diagnostic accuracy study of infants under 90 days old, who were studied for unexplained fever without any source, in the emergency room of a hospital in Madrid from January 2011 to January 2013. We obtained matched samples of urine using two different methods: a clean-catch, standardised stimulation technique and catheterisation collection. The results of the leucocyte esterase test and nitrite test were compared with their urine cultures. RESULTS: We obtained 60 pairs of matched samples. A combined analysis of leukocyte esterase and, or, nitrites yielded a sensitivity of 86% and a specificity of 80% for the diagnosis of UTIs in clean-catch samples. The sensitivity of leukocyte esterase and, or, nitrites in samples obtained by catheterisation were not statistically different to the clean-catch samples (p = 0.592). CONCLUSION: Performing urine dipstick tests using urine samples obtained by the clean-catch method was an accurate screening test for diagnosing UTIs in febrile infants of less than 90 days old. This provided a good alternative to bladder catheterisation when screening for UTIs.
Asunto(s)
Infecciones Urinarias/diagnóstico , Toma de Muestras de Orina , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Tiras Reactivas , Infecciones Urinarias/orinaRESUMEN
OBJECTIVE: To evaluate the accuracy of diagnosing urinary tract infections using a new, recently described, standardized clean-catch collection technique. METHODS: Cross-sectional study of infants <90 days old admitted due to fever without a source, with two matched samples of urine obtained using two different methods: clean-catch standardized stimulation technique and bladder catheterization. RESULTS: Sixty paired urine cultures were obtained. The median age was 44-days-old. Seventeen percent were male infants. Clean-catch technique sensitivity was 97% (95% CI 82% to 100%) and specificity was 89% (95% CI 65% to 98%). The contamination rate of clean-catch samples was lower (5%) than the contamination rate of catheter specimens (8%). CONCLUSIONS: The sensitivity and specificity of urine cultures obtained using the clean-catch method through the new technique were accurate and the contamination rate was low. These results suggest that this technique is a valuable, alternative method for urinary tract infection diagnosis.
OBJECTIF: Évaluer l'exactitude des diagnostics d'infection urinaire au moyen d'une technique de prélèvement d'urine propre standardisée décrite récemment. MÉTHODOLOGIE: Étude transversale de nourrissons de moins de 90 jours hospitalisés à cause d'une fièvre sans source connue disposant de deux prélèvements d'urine appariés obtenus par deux méthodes différentes : la technique de prélèvement d'urine propre par stimulation standardisée et le cathétérisme vésical. RÉSULTATS: Les chercheurs ont obtenu 60 prélèvements d'urine appariés. Les nourrissons avaient un âge médian de 44 jours, et 17 % étaient de sexe masculin. La sensibilité de la technique par prélèvement d'urine propre s'élevait à 97 % (95 % IC 82 % à 100 %) et sa spécificité, à 89 % (95 % IC 65 % à 98 %). Le taux de contamination des prélèvements d'urine propre était plus faible (5 %) que celui des prélèvements par cathétérisme (8 %). CONCLUSIONS: La sensibilité et la spécificité des cultures d'urine prélevées au moyen de la nouvelle technique de prélèvement d'urine propre étaient précises, et le taux de contamination, faible. Selon ces résultats, cette technique est une solution précieuse pour diagnostiquer les infections urinaires.
RESUMEN
Congenital ADAMTS13 deficiency is a rare disease that leads to recurrent episodes of thrombotic thrombocytopenic purpura. We report a case that mimicked a recurring immune thrombocytopenic purpura in a child. Mild cases of ADAMTS13 deficiency may be initially confused with immune thrombocytopenic purpura if hemolytic anemia is not severe and renal or neurological symptoms are not present. Fresh frozen plasma is the treatment of choice in acute thrombotic thrombocytopenic purpura in ADAMTS13-deficient patients. The best long-term treatment for slightly symptomatic cases remains to be elucidated. Recombinant human ADAMTS13 factor will be a promising option when commercially available.
Asunto(s)
Proteínas ADAM/deficiencia , Anemia Hemolítica/diagnóstico , Púrpura Trombocitopénica Idiopática/diagnóstico , Púrpura Trombocitopénica Trombótica/diagnóstico , Proteínas ADAM/inmunología , Proteína ADAMTS13 , Anemia Hemolítica/inmunología , Preescolar , Diagnóstico Diferencial , Femenino , Humanos , Lactante , Masculino , Púrpura Trombocitopénica Idiopática/inmunología , Púrpura Trombocitopénica Trombótica/inmunología , HermanosRESUMEN
Recurrence of focal segmental glomerulosclerosis (FSGS) after renal transplantation can limit graft survival. Despite new immunosuppressive agents, the incidence of recurrence remains relatively high. To identify risk factors for recurrence and efficacy of treatment, we reviewed the outcome of 23 grafts in 16 children with FSGS who had undergone transplantation between 1985 and 2007 at La Paz Children's Hospital. Recurrence was 56.3% after the first transplantation. We did not find significant differences in age at diagnosis, age at transplantation, age at end-stage renal disease (ESRD), progression to ESRD, bilateral nephrectomy of native kidneys prior to transplantation, use of induction therapy or of different immunosuppressive regimens between patients with and without recurrence. Plasmapheresis (PP) was carried out in seven of nine patients who had suffered recurrence, achieving remission in six of them. One patient received high doses of cyclosporin (CsA) and plasmapheresis, attaining remission. Graft survival was lower (P = 0.043) in patients with FSGS than in those with other ESRD etiologies (first year 75% vs 91%; fifth year 44% vs 78%). Recurrence of FSGS limited graft survival (first year 66% vs 85%; third year 20% vs 68%) (P = 0.07). In our experience, PP can be effective in treating FSGS recurrence, although its effect on long-term graft survival seems more limited.
Asunto(s)
Glomeruloesclerosis Focal y Segmentaria/cirugía , Trasplante de Riñón/fisiología , Adolescente , Antiinflamatorios/uso terapéutico , Niño , Preescolar , Ciclosporina/efectos adversos , Ciclosporina/uso terapéutico , Progresión de la Enfermedad , Femenino , Glomeruloesclerosis Focal y Segmentaria/patología , Rechazo de Injerto/epidemiología , Rechazo de Injerto/prevención & control , Supervivencia de Injerto/fisiología , Humanos , Inmunosupresores/efectos adversos , Inmunosupresores/uso terapéutico , Riñón/patología , Fallo Renal Crónico/cirugía , Masculino , Metilprednisolona/uso terapéutico , Nefrectomía , Plasmaféresis , Proteinuria/epidemiología , Proteinuria/etiología , Recurrencia , Factores de Riesgo , Análisis de Supervivencia , Resultado del Tratamiento , Adulto JovenRESUMEN
Diffuse mesangial sclerosis (DMS) is a renal disease that usually presents as a nephrotic syndrome. It is characterized by early onset and rapid progression to end-stage renal disease, and can occur as an isolated finding or as part of the Denys-Drash syndrome. The aim of this study was to characterize clinical features and outcomes of DMS in a cohort of children. We retrospectively analyzed all cases of DMS diagnosed in our hospital between 1973 and 2008 and evaluated the progression of the disease in relation to different variables. We studied 14 patients, four with incomplete Denys-Drash syndrome and one with Frasier syndrome. All patients developed renal failure. Eight patients received a renal transplant with no relapse of the disease. Bilateral nephrectomy was performed in nine patients with end-stage renal disease. Seven patients died, with sepsis being the main cause of death. Diffuse mesangial sclerosis must be suspected in a child that presents with early onset proteinuria and/or rapidly progressive renal failure. Karyotype and WT1 gene analysis should be performed because of the predisposition of patients to develop different types of tumors. This nephropathy has a poor prognosis, but the survival rate has improved in the last decade.
Asunto(s)
Mesangio Glomerular/patología , Nefroesclerosis/patología , Síndrome Nefrótico/patología , Insuficiencia Renal/patología , Preescolar , Estudios de Cohortes , Síndrome de Denys-Drash/patología , Diagnóstico Diferencial , Progresión de la Enfermedad , Femenino , Síndrome de Frasier/diagnóstico , Humanos , Lactante , Recién Nacido , Trasplante de Riñón , Masculino , Nefroesclerosis/mortalidad , Nefroesclerosis/cirugía , Síndrome Nefrótico/mortalidad , Síndrome Nefrótico/cirugía , Insuficiencia Renal/mortalidad , Insuficiencia Renal/cirugía , Estudios Retrospectivos , Tasa de SupervivenciaRESUMEN
AIM: To describe and test a new technique to obtain midstream urine samples in newborns. DESIGN AND METHODS: This was a prospective feasibility and safety study conducted in the neonatal unit of University Infanta Sofía Hospital, Madrid. A new technique based on bladder and lumbar stimulation manoeuvres was tested over a period of 4 months in 80 admitted patients aged less than 30 days. The main variable was the success rate in obtaining a midstream urine sample within 5 min. Secondary variables were time to obtain the sample and complications. RESULTS: This technique was successful in 86.3% of infants. Median time to sample collection was 45 s (IQR 30). No complications other than controlled crying were observed. CONCLUSIONS: A new, quick and safe technique with a high success rate is described, whereby the discomfort and waste of time usually associated with bag collection methods can be avoided.